BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 6928622)

  • 21. Monitoring the bioenergetics of cardiac allograft rejection using in vivo P-31 nuclear magnetic resonance spectroscopy.
    Canby RC; Evanochko WT; Barrett LV; Kirklin JK; McGiffin DC; Sakai TT; Brown ME; Foster RE; Reeves RC; Pohost GM
    J Am Coll Cardiol; 1987 May; 9(5):1067-74. PubMed ID: 3553275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of acidosis in the ischaemic heart by phosphorus nuclear magnetic resonance.
    Garlick PB; Radda GK; Seeley PJ
    Biochem J; 1979 Dec; 184(3):547-54. PubMed ID: 44193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 31P-NMR measurements of pHi and high-energy phosphates in isolated turtle hearts during anoxia and acidosis.
    Wasser JS; Inman KC; Arendt EA; Lawler RG; Jackson DC
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R521-30. PubMed ID: 2396711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gated in vivo examination of cardiac metabolites with 31P nuclear magnetic resonance.
    Kantor HL; Briggs RW; Metz KR; Balaban RS
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H171-5. PubMed ID: 3728693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transsarcolemmal movement of inorganic phosphate in glucose-perfused rat heart: a 31P nuclear magnetic resonance spectroscopic study.
    Polgreen KE; Kemp GJ; Clarke K; Radda GK
    J Mol Cell Cardiol; 1994 Feb; 26(2):219-28. PubMed ID: 8006983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy.
    Sieverding L; Jung WI; Breuer J; Widmaier S; Staubert A; van Erckelens F; Schmidt O; Bunse M; Hoess T; Lutz O; Dietze GJ; Apitz J
    Am J Cardiol; 1997 Aug; 80(3A):34A-40A. PubMed ID: 9293954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioenergetic abnormalities associated with severe left ventricular hypertrophy.
    Zhang J; Merkle H; Hendrich K; Garwood M; From AH; Ugurbil K; Bache RJ
    J Clin Invest; 1993 Aug; 92(2):993-1003. PubMed ID: 8349829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [31P-NMR analysis of high energy phosphorous compounds (ATP and phosphocreatine) in the living rat brain--effects of halothane anesthesia and a hypoxic condition].
    Yuasa T; Miyatake T; Kuwabara T; Umeda M; Eguchi K
    No To Shinkei; 1983 Nov; 35(11):1089-95. PubMed ID: 6661335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR visibility of Pi in perfused rat hearts is affected by changes in substrate and contractility.
    Garlick PB; Townsend RM
    Am J Physiol; 1992 Aug; 263(2 Pt 2):H497-502. PubMed ID: 1510146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased cardiac Pi/PCr in the diabetic heart observed using phosphorus magnetic resonance spectroscopy at 7T.
    Valkovič L; Apps A; Ellis J; Neubauer S; Tyler DJ; Schmid AI; Rider OJ; Rodgers CT
    PLoS One; 2022; 17(6):e0269957. PubMed ID: 35709167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorus-31 nuclear magnetic resonance analysis of transient changes of canine myocardial metabolism in vivo.
    Heineman FW; Balaban RS
    J Clin Invest; 1990 Mar; 85(3):843-52. PubMed ID: 2312728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR-visible ATP and Pi in normoxic and reperfused rat hearts: a quantitative study.
    Humphrey SM; Garlick PB
    Am J Physiol; 1991 Jan; 260(1 Pt 2):H6-12. PubMed ID: 1992810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Energy Deregulation Precedes Alteration in Heart Energy Balance in Young Spontaneously Hypertensive Rats: A Non Invasive In Vivo31P-MR Spectroscopy Follow-Up Study.
    Deschodt-Arsac V; Arsac L; Magat J; Naulin J; Quesson B; Dos Santos P
    PLoS One; 2016; 11(9):e0162677. PubMed ID: 27622548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between the phosphocreatine to ATP ratio determined by 31P nuclear magnetic resonance spectroscopy and left ventricular function in underperfused guinea-pig heart.
    Brooks WM; Haseler LJ; Clarke K; Willis RJ
    J Mol Cell Cardiol; 1986 Feb; 18(2):149-55. PubMed ID: 3959089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Energy metabolism of the hypertrophied heart studied by 31P nuclear magnetic resonance.
    Aussedat J; Lortet S; Ray A; Rossi A; Heckman M; Zimmer HG; Vincent M; Sassart J
    Cardioscience; 1992 Dec; 3(4):233-9. PubMed ID: 1477290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium].
    Schindler R; Krahe T; Neubauer S; Hillenbrand H; Entzeroth C; Horn M; Lackner K; Ertl G
    Rofo; 1992 Nov; 157(5):452-7. PubMed ID: 1421185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PGE1 and iloprost affect the high energy phosphates in the global ischemic and reperfused rat heart: a 31P-NMR study.
    Pissarek M; Gründer W; Keller T; Lindenau KF; Krause EG
    Biomed Biochim Acta; 1989; 48(1):43-50. PubMed ID: 2476119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 31P magnetic resonance spectroscopy of the Sherpa heart: a phosphocreatine/adenosine triphosphate signature of metabolic defense against hypobaric hypoxia.
    Hochachka PW; Clark CM; Holden JE; Stanley C; Ugurbil K; Menon RS
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1215-20. PubMed ID: 8577743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The detection of chronic heart graft rejection by 31P NMR spectroscopy.
    Suzuki K; Hamano K; Ito H; Fujimura Y; Esato K
    Surg Today; 1999; 29(2):143-8. PubMed ID: 10030739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the protective effect of phosphocreatine on the ischemic myocardium during cardioplegia using the P-31 NMR method].
    Kupriianov VV; Shteĭnshneĭder AIa; Lakomkin VL; Ruuge EK; Kapel'ko VI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):14-9. PubMed ID: 4005052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.